» Articles » PMID: 9596773

Trypanosoma Cruzi Infection in Tumor Necrosis Factor Receptor P55-deficient Mice

Overview
Journal Infect Immun
Date 1998 May 29
PMID 9596773
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor necrosis factor receptor p55 (TNFRp55) mediates host resistance to several pathogens by allowing microbicidal activities of phagocytes. In the studies reported here, TNFRp55-/- mice infected with the intracellular parasite Trypanosoma cruzi showed clearly higher parasitemia and cumulative mortality than wild-type (WT) controls did. However, gamma interferon (IFN-gamma)-activated macrophages from TNFRp55-/- mice produced control levels of nitric oxide and killed the parasite efficiently in vitro. Trypanocidal mechanisms of nonphagocytic cells (myocardial fibroblasts) from both TNFRp55-/- and WT mice were also activated by IFN-gamma in a dose-dependent way. However, IFN-gamma-activated TNFRp55-/- nonphagocytes showed less effective killing of T. cruzi than WT control nonphagocytes, even when interleukin 1beta (IL-1beta) was added as a costimulator. In vivo, T. cruzi-infected TNFRp55-/- mice and WT mice released similar levels of NO and showed similar levels of IFN-gamma mRNA and inducible nitric oxide synthase mRNA in their tissues. Instead, increased susceptibility to T. cruzi of TNFRp55-/- mice was associated with reduced levels of parasite-specific immunoglobulin G (IgG) (but not IgM) antibodies during infection, which is probably linked to abnormal B-cell differentiation in secondary lymphoid tissues of the mutant mice. Surprisingly, T. cruzi-infected TNFRp55-/- mice showed increased inflammatory and necrotic lesions in several tissues, especially in skeletal muscles, indicating that TNFRp55 plays an important role in controlling the inflammatory process. Accordingly, levels of Mn2+ superoxide dismutase mRNA, a TNF-induced enzyme which protects the cell from the toxic effects of superoxide, were lower in mutant than in WT infected mice.

Citing Articles

Achieving the Optimal AgO Concentrations to Modulate the Anti- Activity of Ag-ZnO/AgO Nanocomposites: In Vivo Investigations.

Rodrigues do Carmo Neto J, Braga Y, Franco P, de Oliveira J, Trevisan R, Mendes K Pharmaceutics. 2024; 16(11).

PMID: 39598539 PMC: 11597568. DOI: 10.3390/pharmaceutics16111415.


Enhanced Migratory Capacity of T Lymphocytes in Severe Chagasic Patients Is Correlated With VLA-4 and TNF-α Expression.

Berbert L, Gonzalez F, Villar S, Vigliano C, Lioi S, Beloscar J Front Cell Infect Microbiol. 2021; 11:713150.

PMID: 34796122 PMC: 8593233. DOI: 10.3389/fcimb.2021.713150.


Host-parasite dynamics in Chagas disease from systemic to hyper-local scales.

Perez-Mazliah D, Ward A, Lewis M Parasite Immunol. 2020; 43(2):e12786.

PMID: 32799361 PMC: 11475410. DOI: 10.1111/pim.12786.


Unconventional Pro-inflammatory CD4 T Cell Response in B Cell-Deficient Mice Infected with .

Serran M, Tosello Boari J, Fiocca Vernengo F, Beccaria C, Ramello M, Bermejo D Front Immunol. 2017; 8:1548.

PMID: 29209313 PMC: 5702327. DOI: 10.3389/fimmu.2017.01548.


Tumor necrosis factor is a therapeutic target for immunological unbalance and cardiac abnormalities in chronic experimental Chagas' heart disease.

Resende Pereira I, Vilar-Pereira G, Silva A, Cruz Moreira O, Britto C, Sarmento E Mediators Inflamm. 2014; 2014:798078.

PMID: 25140115 PMC: 4130030. DOI: 10.1155/2014/798078.


References
1.
Flynn J, GOLDSTEIN M, Chan J, Triebold K, Pfeffer K, Lowenstein C . Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 1995; 2(6):561-72. DOI: 10.1016/1074-7613(95)90001-2. View

2.
MacMicking J, Nathan C, Hom G, Chartrain N, Fletcher D, Trumbauer M . Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell. 1995; 81(4):641-50. DOI: 10.1016/0092-8674(95)90085-3. View

3.
Steinshamn S, Bemelmans M, van Tits L, Bergh K, Buurman W, Waage A . TNF receptors in murine Candida albicans infection: evidence for an important role of TNF receptor p55 in antifungal defense. J Immunol. 1996; 157(5):2155-9. View

4.
Hsu H, Xiong J, Goeddel D . The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell. 1995; 81(4):495-504. DOI: 10.1016/0092-8674(95)90070-5. View

5.
De Titto E, Catterall J, Remington J . Activity of recombinant tumor necrosis factor on Toxoplasma gondii and Trypanosoma cruzi. J Immunol. 1986; 137(4):1342-5. View